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ABSTRACT
Management of Cervical Intraepithelial Neoplasia (CIN) includes a long time course of 
surveillance in which many women are “lost to follow-up.” Inadequate management of early 
dysplastic changes that may progress to CIN contributes to an increased likelihood of mortality 
from invasive cervical cancer in the state of North Carolina. The aim of this qualitative study is 
to understand women’s knowledge and perceptions of cervical dysplasia in order to tailor 
counseling for improved follow-up. Thirteen women with varying levels of cytological 
abnormalities from pap smear screening were interviewed prior to their colposcopy appointment 
at a referral hospital. In addition to recalling significant anxiety and fear about the possibility of 
cancer, women exhibited an unexpected lack of knowledge about cervical dysplasia and human 
papilloma virus (HPV) despite counseling at previous clinics. Financial and cost barriers were 
less significant to seeking care than understanding of prognosis. This study reveals an 
opportunity for better pre-testing and pre-screening counseling about the causal role of HPV and
the potential disease course following cytological abnormalities to increase women’s likelihood 
of referral follow-up.
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INTRODUCTION
Cytological abnormalities are detected in approximately 5% of pap smears in the United States, 
peaking in women of reproductive age.1 These abnormalities are then confirmed and staged 
through examination with colposcopy and cervical biopsy. Human papilloma virus (HPV) is a 
precursor to cervical intraepithelial neoplasia (CIN) and cancer. Although the body’s immune 
system is able to clear most HPV infections, persistent dysplasia requires aggressive follow-up
and excision if lesions progress to high grade dysplasia (CIN 2– 3) or invasive cervical cancer. 
Current treatment guidelines for low-grade dysplasia (CIN 1) include regular surveillance with 
colposcopy and biopsy at six- to 12– month intervals2 Cervical cancer screening programs cost 
approximately $2.3 billion yearly with management of dysplasia costing $1,275 – $2,349 per 
case.3 Follow-up failure rates have been estimated to be as high as 70%, indicating not only 
disruption to clinical practice, but also a failure in service delivery.4
The objective of this study is to examine factors that contribute to women’s lack of follow up 
after abnormal pap smear for diagnosis and treatment. In central North Carolina, many public 
health departments refer women with abnormal pap smears to the UNC Women’s Hospital 
Dysplasia Clinic. This regional referral center serves over 1200 women per year, approximately 
150-180 of whom have high grade dysplasia that requires excisional treatment. In 2011, the 
clinic patient population was 23.6% non-Hispanic black, 44.6% non=Hispanic white, and 26.2% 
Latina and 5.6% other according to the hospital’s intake demographics., The clinic provides 
services to many women who are uninsured; only 17.8% of the clinic’s patient filed private 
insurance claims and 13.3% were enrolled in the Medicaid or Medicare program in 2011. 
Despite “Charity Care” covering 27.6% of the clinic’s patients, 41.3% were classified as “Self-
pay” and paid for services out of pocket. The demographics of the patient population of the UNC 
Dysplasia Clinic represent women whose marginalized status as minorities and lack of insurance 
increase vulnerability to substandard surveillance and more serious health outcomes.4
Without appropriate diagnosis and treatment procedures following an abnormal pap smear, 
lesions may progress to high grade dysplasia or invasive cervical cancer. The North Carolina 
cervical cancer rate is higher than the US rate (9.4 versus 7.7 women per 100,000, respectively); 
rural North Carolina counties have annual cervical cancer incidence and mortality rates up to 
twice that of national US rates.6 The Carolina Framework created by Cervical Cancer Free NC
initiative cites inadequate follow-up care after abnormal screening results as causing one in ten 
cervical cancer deaths, disproportionately affecting minority women and rural groups.7 Lack of 
insurance and poor access to medical services have been cited as barriers to rural women 
receiving pap smears which may explain their higher risk of cervical cancer mortality.8 Systems-
based barriers to care such as appointment cost and travel time have been known to decrease 
clinic attendance for cervical cancer screening programs;7 however, these barriers have not been 
analyzed in a qualitative fashion or compared to less tangible barriers. Qualitative interviews 
would allow evaluation of “shadow costs” of environmental constraints associated with clinic 
attendance, such as childcare, transportation, and missed time at work. These obstacles may 
contribute to women not attending referral appointments at the UNC Dysplasia Clinic, since the 
majority of the patient population is uninsured and travel considerable distances. Many women 
referred to the UNC Dysplasia Clinic already have a history of cytological abnormalities; 
although first referrals for low-grade lesions are common. Twelve percent of women presented to 
the clinic with a history of CIN 2 –3 in 2011; these women are at the highest risk for invasive 
cervical carcinoma. The purpose of the study is to explore how informational, emotional, and 
logistical processes that follow receiving abnormal cytology results affect women’s decisions to 
attend medical follow-up at a referral hospital.
METHODS
Recruitment
This is a descriptive, qualitative study of barriers to diagnosis and treatment for cytological
abnormalities detected by pap smear screening. Qualitative research methods allow for deductive 
investigation of hypothesized barriers to care as well as inductive discovery of other contributory 
factors. For this study, adult English-speaking patients new to the UNC Women’s Hospital 
Dysplasia Clinic were interviewed prior to their referral appointment for colposcopy. Women 
who met inclusion criteria were recruited following examination of vital signs by a nursing 
assistant. Rather than having to return to the clinic waiting room until the time of their clinical 
evaluation, women were offered an opportunity to participate in the study. Patients who were 
interested in participating in what was described as a brief interview on their experiences with 
cervical dysplasia were brought to a private exam room. Participants were compensated with a 
two-hour parking pass. The interviewer obtained verbal consent based on an IRB-approved script 
that emphasized anonymity, confidentiality, and lack of influence on their subsequent medical 
care. So as not to influence questions and probes, patients’ dysplasia histories were retrieved by a
second researcher who did not interview participants.
Interviews
A semi-structured guide was used for interviews with questions based on literature review and 
pre-interview hypotheses; however, the open-ended nature of the questions was designed to 
capture experiences outside the realm of hypotheses. Based on patient demographics and 
interactions within the UNC Dysplasia Clinic, we hypothesized that psychological impact of 
diagnosis, lack of knowledge about cervical dysplasia, and the cumulative “cost,” both financial 
and in terms of convenience, would be the most significant barriers to attending referral 
colposcopy appointments. A conceptual model for barriers to care can be found in Appendix 1. 
Questions were designed to initiate discussion within the broad topics of psychological impact, 
knowledge, and cost with probes directed at education, insurance, and overall impact of 
diagnosis. The interview guide is included in Appendix 2. 
Interviews were conducted by a fourth year medical student during clinic hours. Sample size was 
estimated to be approximately 20 patients or until redundancy of responses was met. Participants 
were recruited using convenience sampling and were considered to be representative of the clinic 
patient population based on available demographic information from the clinic’s quantitative 
database. 
Analysis
Interviews were audio-recorded and transcribed verbatim. Transcripts were analyzed using a 
grounded-theory approach to discover emerging themes. Interview questions were designed to 
assess perceptions of disease based on knowledge and attitude as well as logistic difficulties in 
attending clinic, but responses were coded regardless of question. The data were coded by the 
interviewer in Atlas.ti.6. Initial analysis of the text through reading at face value generated 
repeated words and meanings which were labeled as codes. On second reading, these codes were 
grouped according to similar topics that had recurred throughout multiple interviews. These 
topics were then related to important themes from previous research and to the investigation’s 
hypothesis that determined women’s responses to diagnosis and their actions in maintaining 
surveillance. 
RESULTS
Thirteen women were interviewed between February and April 2012. No women declined to be 
interviewed. By the time 13 women had been interviewed, saturation of responses had been met 
and themes had emerged according to both prior hypotheses and new themes through induction.
Liminality and Cancer
In describing their initial reaction of receiving abnormal pap smear results, almost every 
participant noted significant emotional distress. While this reaction dissipated over time and was 
alleviated by receiving more information and explanation of the results, a residual ambiguity 
persisted between their hopes and fears. Previous qualitative research on women’s experiences 
with cervical dysplasia described the rite of passage between health and disease as “liminality,” a 
term that encompasses the uncertainty inherent in the transition from receiving normal versus 
abnormal pap smear results.8
Many women noted that they never anticipated receiving abnormal results and quite a few were 
unaware of what was being screened during a pap smear. One woman noted she only underwent 
pap smear screening as a stipulation to receive birth control and was therefore unprepared for 
receiving abnormal results. Once they received abnormal results, women oscillated between 
fearing the potential for cancer and believing that the abnormality would resolve. The difficulty 
in finding the appropriate balance between reassurance and alarm was exhibited in one 
participant’s desire for more information:
Um, I had to ask a lot of questions to find out what I wanted to know. I don’t feel like a lot was 
told to me up front. I feel like they were kinda minimizing a lot of things just to make me feel 
better and I wanted to know the worst case scenario of where this could go. And I wanted to be 
realistic as to where we were; I didn’t want to brush anything under the rug either. I want[ed] to
know how bad it could be and I don’t feel like that was really explained to me. I had a lot of 
questions. 
Some women experienced mixed feelings to the word “cancer” being used by providers in 
explaining the need for referral appointments. Many women noted that the possibility of cancer 
made the need for diagnosis of cervical dysplasia seem serious and motivated them to seek 
further care. In addition, referencing “cancer” also helped eliminate ambiguities in terminology:
It’s very scary because you don’t know what abnormal means. And then they say you have some 
dysplasia, and I didn’t really know what that meant as far as, you know, what that entailed and,
you know, how serious it was. And then, you know, they say the word “cancer,” and you’re like, 
Oh my God, Cancer?!
Many women described a perpetual residue of anxiety persisting after the initial upset from 
diagnosis had resolved, often linked to their fear of cancer. The phrase “back of your mind” was 
used by multiple women:
You always worry in the back of your head, is this going to need surgery? Is this going to lead to 
something, cancer or something else like that. It’s always on your mind. No matter how bad, they 
can be like, ‘it can or it can’t be’ but, girl, you know, always in the back of your mind, it could 
lead to that. 
Liminality acknowledges the pervasive sense of disorder that accompanies a diagnosis of 
cervical dysplasia and the experience of existing in a state between health and illness. The 
counterintuitive persistence of anxiety despite increased knowledge and education was 
recognized by many women:
Then after I started gathering information up on it and stuff, it was really not, really anything to 
be nervous about, not really, but it does still kinda make me nervous.
Persistent low levels of anxiety and fear appeared to motivate these women to attend referral 
appointments. Of the 13 women interviewed, only 2 cited their anxiety and fear as causing delay 
or procrastination in seeking follow-up. Most women suggested their fears of cancer served as 
motivation to ensure rigorous surveillance and took pride in being pro-active regarding their 
health. 
Fears about Fertility
Concerns about the impact of cervical dysplasia on future fertility desires was an unexpected
finding that emerged throughout the course of interviews and was shared by the majority of 
women. Two women were specifically concerned about the association between excisional 
treatment and preterm birth, although more women were able to articulate a general fear about 
cervical dysplasia affecting their ability to have children:
Because it’s major for me, because, for me personally. I want another child but I don’t– it was 
hard for me to get my first one, so I don’t want [it] to be, like, anything that would prolong 
having another one. You know, I don’t want to be, like, forty years old when I’m pregnant, or 
not being able to have kids at all. So it, that was major for me.
Three women received their first abnormal pap smear during or following pregnancy which 
negatively impacted their feelings about childbearing. One woman was concerned that she could 
have given her son HPV in utero and had associative feelings of guilt. Two women associated 
pregnancy with dysplasia. Their abnormal pap smears during pregnancy discouraged them from
future child bearing despite a previous desire for more children:
‘Cause I never had anything like this, so as soon as I had my baby, I mean, that’s when 
everything started changing in me and that’s when they told me I had an abnormal pap smear. So 
I guess that was the problem, but I don’t know. But I don’t really want to have any more kids 
right now. Not right now. . . Yeah, I wanted a boy and a girl. Now I just have my little girl and I 
don’t want any more. 
Fears about fertility compounded fears about mortality, both of which are unusual thoughts for 
young women of reproductive age, introduced with the diagnosis of cervical dysplasia. The 
gravity of these concerns served as motivation for women to seek more information, both 
independently and through their healthcare provider at appointments. Uncertainty pervaded 
women’s responses to abnormal pap smears as they questioned both what their prognosis 
entailed and how they had acquired the abnormality. 
Causal Connections
All women described wanting to know more about the causes of abnormal pap smears. Many 
were interested in why they had an abnormal result and what means existed to prevent 
recurrences in the future. These causal questions were also linked to anxiety:
That’s probably the hardest part about it, like with anything. When you find out, it’s all the “Why 
me?” questions and how do I deal with it, what do I do to fix it, and is it fixable. And those are 
the worrisome things. I try not to bog myself down with it a lot. I don’t, you know, want to 
become depressed or anything like that. I don’t think it’s that serious, but it’s still really, really 
hard. 
These concerns suggest a paucity of understanding about the nature of HPV and its influence on 
cervical dysplasia. One of the three women who mentioned HPV and knew that a vaccine existed 
still didn’t understand the causal connection between HPV and abnormal pap smears. As 
interviews progressed, questions probing women’s knowledge of HPV were included and their 
answers confirmed the lack of awareness. The few women who did know about HPV still desired 
more education and increased awareness:
Because, to me, HPV isn’t something I heard about until I was like 20 and I’m only 24, and you 
know what I mean, if it has been around for as long as it has, well, like, why don’t we, you 
know, have any more information. You know, why aren’t people, you know, informed sooner.  
Although women had difficult existential questions of why they had received bad news, they also 
had a number of factual questions about the nature of their condition, questions that remained 
unanswered after their initial results. Lack of understanding about cervical dysplasia was not 
limited to HPV and spanned a breadth of topics ranging from hygiene to pregnancy. 
Myths and Misconceptions
In addition to a lack of knowledge about HPV and cervical dysplasia, many women had 
misconceptions) about the screening process. Two women believed personal hygiene practices 
such as soaps and vaginal douching caused abnormal pap smears. One woman believed she was 
being screened for ovarian cancer:
Um, I don’t know. I really was thinking, like, I guess, to avoid the ovarian cancer 
and the problems that women have. My thing was mostly fertility, and making 
sure we can still reproduce and stuff, and keep check of the ovaries and stuff like 
that. 
Another woman believed that she already had disseminated cancer that was causing fatigue and 
weight loss. Only three women had understood, before receiving their first abnormal result, that 
pap smears screened for cervical cancer.
A number of women struggled with even pronouncing the term “colposcopy” and physically 
appeared flustered. This physical representation correlated with their overall lack of health 
literacy, with regard to cervical cancer screening, diagnosis, and treatment. Most women 
referenced doing research though the Internet and friends or relatives, especially those in 
healthcare fields, to learn more about the causes of cervical dysplasia and expressed desire for 
more information from their physicians. They also mentioned that they had to ask questions in 
order to learn more about their results rather than being educated by their health care providers
during their clinic visits or on receipt of results:
I kinda researched myself, in particular, and I told the doctor that I went on the Internet. And he 
said, you know, sometimes the Internet is not the best place for you because it can scare you. 
And it scared me, I was like, Wooo.
The use of phone calls and letters to give the diagnosis was also described by the women as 
alienating, in that it precluded reassuring explanation and information about the meaning of an 
abnormal pap smear. In addition to most women conducting research on their own, many of 
them turned to a support person, often a friend, sister, or mother, for information and 
reassurance, support that was also utilized in attending their referral appointments. 
Minimizing Logistical Barriers
Despite a stated average transportation time of a 45 – minute drive and a majority with lack of 
insurance, only two women cited these as reasons why they had missed appointments. Even after 
numerous probes about missed work, childcare, and transportation, most women brushed aside 
these inconveniences as trivial when compared to their perception of prioritizing health. As one 
participant succinctly surmised, “No, I mean, you gotta do what you gotta do. I mean, I take my 
health very seriously.” The autonomous decision to seek health care seems to be a self-
perpetuating phenomenon among participants and even a source of pride. 
Lack of insurance was mentioned by a few women as a barrier to care, albeit one superseded by 
the perceived importance of follow-up:
I would come regardless of if I had to rack up hundreds of thousands in bills, you know. But, it’s 
like, you don’t want to be in debt either [laughs] You know. But I haven’t had insurance since I 
was 18, so, you learn to deal with it. You don’t go to the doctor when you should go, and you 
pass it off until you absolutely have to, you know. . .Because they told me I could have cancerous 
cells and I don’t want to–  that’s not something that you play with.  
The unfortunate abnormal pap smear results and the follow-up appointment that ensued were 
often the women’s only interactions with the healthcare system. Many were screened during their 
pregnancies, indicating an important time for education and the need for thorough informed 
consent about what is being screened for and why. 
Trust in Referral Center
While we initially hypothesized that the journey to the referral center was a burden for 
colposcopy patients, a number of women said they preferred receiving care at UNC as opposed 
to their local health departments. They mentioned a high level of trust in the care, as well as 
freedom from judgment. Two women said they appreciated the increased anonymity of receiving 
care outside their towns:
You know, I know a lot of people and my family knows a lot of people and even for, I mean, 
being down here, they serve everybody and I don’t feel like I’m going to run into somebody that 
I know. I know there are laws and there’s confidentiality and things that you can’t break but at 
the same time, when you know somebody and you see somebody, you’re like, Oh, they know. 
And I just feel like there’s more chance for something to get out and, you know. I’ve always had 
a great experience here.
Positive experiences at the referral center were also characterized by thorough education. The 
women praised the reputation of the hospital and the programs put in place for those without 
insurance.
DISCUSSION
The aims of this study were to explore in depth the psychological, knowledge-based, and cost-
related barriers to follow-up that prevent women from being adequately screened following an 
abnormal cytology result. Qualitative interviews allowed an in-depth investigation of women’s 
knowledge and perceptions about their disease process that identified numerous areas for 
improvement in patient education. Results suggest that women are less likely to let 
environmental constraints and costs prevent follow-up when they firmly believe their health is at 
stake. Although lack of insurance created an obstacle to care-seeking, the availability of care at 
the referral site was believed by most women to be acceptable and even preferable.
Few studies have examined non-system–based barriers to follow-up for cervical dysplasia. A 
systematic review of factors associated with follow-up care for an abnormal pap smear indicates 
a wide variety of influences, ranging from characteristics of the patient, psychosocial factors, and 
aspects of the healthcare system.10 Women’s knowledge and perceptions about cervical dysplasia 
may influence their decisions to seek care and maintain surveillance of their dysplasia. 
Numerous quantitative and qualitative studies have documented significant psychological 
distress following diagnosis and throughout the surveillance period but don’t examine whether 
this anxiety serves as motivation or intimidation to maintain follow-up.5 In this study, we sought
to determine how the psychological impact of diagnosis, in addition to other structural barriers, 
affected the decision to seek care. 
Knowledge of the causes of cervical dysplasia, particularly the role of HPV, has been found to be 
low among women, even after they received education, including informational pamphlets.11
Although the link between HPV and cervical dysplasia would not address the existential aspect 
of why the women developed dysplasia, increasing scientific knowledge may dispel some 
feelings of confusion or guilt. While lack of knowledge about HPV and dysplasia has been 
linked to increased anxiety,14 how knowledge and anxiety contribute to surveillance has not been 
evaluated. HPV knowledge has been shown to have mixed effects on women’s perception of 
disease, either increasing feelings of stigmatization5,12 or increasing health-related behavior.13
By examining the women’s knowledge about, attitudes toward, and the psychological impact of 
cervical dysplasia, clinicians can learn how to better educate and inform their patients in ways 
that may encourage better surveillance adherence. Our results indicate a need for better pre-
screening informed consent. With many women unaware of the reason for pap smear screening 
until they receive an abnormal result, questions of informed consent during screening are raised. 
Although increased screening is an admirable public health goal, it should not come at the cost of 
women’s health autonomy. Explaining the rationale of screening and the prevalence of abnormal 
results prior to pap smear screening will ideally lessen the psychological shock and anxiety many 
women experience on diagnosis of cervical dysplasia. Education should be favored to help 
women interpret the results of their pap smear, which are increasingly being reflex tested for 
HPV.  HPV screening helps reduce pap smear screening errors, information especially valuable 
to women who are ambivalent about referral follow-up.7 Understanding their HPV status as well 
as the natural course of the disease with immune fluctuations may help answer the common 
question of “Why me?” that arose in many interviews.
Public knowledge of HPV and cervical dysplasia has increased since the development of the 
quadrivalent HPV vaccine. In the years since Gardasil was approved and marketed to prevent 
HPV infections that cause cervical dysplasia, one would hope that knowledge about the causal 
relationship would be better known among the general population. While one in three adolescent 
girls in North Carolina has received the HPV vaccine7; less than 3% of the patients from UNC 
Dysplasia Clinic have been vaccinated. As only a few women interviewed expressed knowledge 
of the vaccine, referral appointments present an opportunity for discussions about the HPV 
vaccine.
Education should not focus solely on HPV but should also address women’s individual concerns, 
which may include mortality and fertility. Concerns for future fertility identify a knowledge gap 
in how excisional treatments affect cervical competence andshould be addressed by providers 
even at the early diagnostic stage. With many misconceptions regarding fertility, it is important 
for providers to counsel using evidence-based research, which is equivocal regarding excisional 
procedures and preterm birth in the US.16 Although concerns about cancer generated fear and 
anxiety that often served as motivation for follow-up, the repeated use of focus on “health” in 
women’s interviews suggests that a positive, pro-active approach may be acceptable and bypass 
risk of undue negative psychological effects.
An important limitation of this study is the selection bias that the women interviewed were those
who were seeking health care and those who were able to overcome logistic barriers. The small 
sample size and recruitment strategy also limit the generalizability of the data. These data does 
not necessarily reflect women who did not come for their referral appointment or women who 
have never even presented for pap smear to start. Because half the women dying from cervical 
cancer were not receiving regular pap smears, this study is does not address those women most at 
risk of presenting with advanced dysplasia.6 Although some interview questions attempted to 
address reasons why women had missed appointments in the past, the women who were able to 
attend clinic may be inherently different from those who frequently miss appointments. Women 
who attend the clinic may have better logistic aid through strong support systems, since many 
noted they had family or friends to drive or provide childcare. Women who attended clinic 
stressed the importance of their health; women lost to follow-up may have a different 
psychological framework to approaching their diagnosis. By interviewing women who did 
follow-up on their referral, we cannot know what reactions are different among women who do 
not follow-up. However, noting the barriers overcome by women interviewed with health 
seeking behaviors provides insight into support and education that may be required to engage 
women who do not engage in health care. Future studies could use telephone contact to interview 
women with multiple missed appointments to address their barriers to follow-up and perhaps 
even provide them compensation for travel or missed work.
Conclusions:
Frequent follow-up appointments for surveillance of cervical dysplasia represent many 
opportunities for more thorough education that may increase referral follow-up and improve 
women’s health outcomes. Uninsured women frequently must overcome several financial and 
geographical barriers to receive care. This study explored the knowledge and perceptions about 
follow-up for abnormal pap smear screening results described by women with health seeking 
behaviors. These data provide information for development of improved pre– and post–
screening education that includes raising HPV awareness in order to promote improved follow-
up for referral visits. 
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Appendix 1:
Pre-test framework for barriers that prevent adequate follow-up and surveillance for abnormal 
cytology results
Abnormal
Pap Smear
Follow-up
 
Knowledge 
 
 
Psychology 
 
 
Cost 
 
Appendix 2:
Interview Guide
Opening: Can you tell me what brings you here today? Prompt: How did they explain that to 
you? What were the doctor’s reasons? What does that mean to you?
Knowledge: What do you think a pap smear is/means? What have you been told about your 
results/needing to follow up? Prompt: What information, if any, do you wish you had been given 
about your pap smear? What questions do you still have? (Those are important to discuss with 
the doctor you are about to see). Overall, do you feel you have been well-informed about cervical 
dysplasia?
Anxiety: How did you feel/think/react when you heard that you had cervical dysplasia? Prompt: 
Have you been affected by having an abnormal pap? How does this change the way you feel 
about your health? What, if any, physical symptoms do you feel? In what ways has having an 
abnormal pap affected you psychologically?
Cost: Where are you from? How did you get here today? What difficulties did you experience in 
coming to the clinic today? Prompt: What transportation did you use? In what ways did coming 
here affect your work? Your childcare? Cues: insurance, out-of-pocket costs, previous missed 
appointments.
Closing: Is there anything you else on your mind about cervical dysplasia that you want to 
discuss or ask?
 
